Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance

Swiss Med Wkly. 2008 Nov 15;138(45-46):665-73. doi: 10.4414/smw.2008.12276.

Abstract

Body weight homeostasis is regulated by central and peripheral mechanisms, in which cytokines appear to have an important role.The circulating levels of the cytokines interleukin 1 (IL-1) and interleukin 18 (IL-18), and of inflammatory mediators such as prostaglandin E2 (PGE2), amongst others, are elevated in obese individuals. The low-grade inflammation associated with obesity may contribute to the development of insulin resistance, impaired glucose tolerance and type 2 diabetes. This review highlights results of studies in mice which indicate important roles for these proinflammatory cytokines during the development of obesity and insulin resistance, and in the treatment of type 2 diabetes.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Body Weight
  • Diabetes Mellitus, Type 2 / etiology*
  • Diabetes Mellitus, Type 2 / therapy
  • Dinoprostone / blood
  • Dinoprostone / physiology*
  • Disease Models, Animal
  • Genotype
  • Homeostasis
  • Insulin Resistance / physiology*
  • Interleukin-1 / blood
  • Interleukin-1 / physiology*
  • Interleukin-18 / blood
  • Interleukin-18 / physiology*
  • Mice
  • Mice, Inbred C57BL / genetics
  • Mice, Knockout / genetics
  • Obesity / blood
  • Obesity / etiology*
  • Obesity / metabolism
  • Phenotype
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Signal Transduction / physiology
  • Time Factors

Substances

  • Interleukin-1
  • Interleukin-18
  • Receptors, Interleukin-1
  • Dinoprostone